Compounds > diethylstilbestrol monoglucuronide
Page last updated: 2024-11-12

diethylstilbestrol monoglucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diethylstilbestrol monoglucuronide: metabolite of diethylstilbestrol; RN given refers to (E)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10411193
MeSH IDM0094565

Synonyms (21)

Synonym
diethylstilbestrol glucuronide
unii-hcs07e193j
(e)-4-(1-ethyl-2-(4-hydroxyphenyl)but-1-enyl)phenyl-beta-d-glucopyranosiduronic acid
2408-40-4
einecs 219-310-4
hcs07e193j ,
diethylstilbestrol monoglucuronide
diethyl stilbestrol beta-d-glucuronide
diethyl stilbestrol |a-d-glucuronide
stilbestrol monoglucuronide
diethyl stilbestrol b-d-glucuronide
W-202004
glucopyranosiduronic acid, p-(.alpha.,.beta.-diethyl-p-hydroxystyryl)phenyl, (e)-, .beta.-d-
.beta.-d-glucopyranosiduronic acid, 4-((1e)-1-ethyl-2-(4-hydroxyphenyl)-1-butenyl)phenyl
95782-00-6
.beta.-d-glucopyranosiduronic acid, 4-(1-ethyl-2-(4-hydroxyphenyl)-1-butenyl)phenyl, (e)-
.beta.-d-glucopyranosiduronic acid, 4-((1e)-1-ethyl-2-(4-hydroxyphenyl)-1-buten-1-yl)phenyl
Q27279866
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(4-((e)-4-(4-hydroxyphenyl)hex-3-en-3-yl)phenoxy)tetrahydro-2h-pyran-2-carboxylic acid
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[4-[(e)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenoxy]oxane-2-carboxylic acid
DTXSID901297869
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
diethylstilbestrol
Diethylstilbestrol: A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed). diethylstilbestrol : An olefinic compound that is trans-hex-3-ene in which the hydrogens at positions 3 and 4 have been replaced by p-hydroxyphenyl groups.		9.1450olefinic compound;
polyphenol		antifungal agent;
antineoplastic agent;
autophagy inducer;
calcium channel blocker;
carcinogenic agent;
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
endocrine disruptor;
xenoestrogen
dienestrol
Dienestrol: A synthetic, non-steroidal estrogen structurally related to stilbestrol. It is used, usually as the cream, in the treatment of menopausal and postmenopausal symptoms.. dienestrol : An olefinic compound that is hexa-2,4-diene substituted by 4-hydroxyphenyl groups at positions 3 and 4 respectively.		3.0510
fosfestrol
fosfestrol: Rx of prostatic carcinoma; RN given refers to parent cpd with unspecified isomeric designation; structure		7.3720aryl phosphate
ConditionIndicatedRelationship StrengthStudiesTrials
Pregnancy
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.		02.8710
Metastase
[description not available]		01.9610
Cancer of Prostate
[description not available]		01.9610
Neoplasm Metastasis
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.		01.9610
Prostatic Neoplasms
Tumors or cancer of the PROSTATE.		01.9610